Recombinant genetically engineered bacterium with high yield of L-homoserine and application of recombinant genetically engineered bacterium

By performing various gene editing and optimization on Corynebacterium glutamicum, a recombinant genetically engineered strain of highly efficient L-homoserine transporter was constructed, solving the problem of low production efficiency in existing technologies and achieving high-yield L-homoserine production.

CN121653028APending Publication Date: 2026-03-13ZHEJIANG UNIV OF TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511874615.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-12-12
Publication Date
2026-03-13

AI Technical Summary

Technical Problem

In existing technologies, chemical synthesis and enzymatic methods for producing L-homoserine suffer from high costs and low efficiency. While microbial fermentation shows potential, it requires additional purification steps. Furthermore, there is limited research on the fermentation of L-homoserine by Corynebacterium glutamicum, and the efficiency and specificity of transport proteins have not been fully utilized.

Method used

By performing various gene editing on Corynebacterium glutamicum, replacing or knocking out specific genes, and overexpressing the thrE gene, highly efficient L-homoserine transporters were screened, recombinant genetically engineered strains were constructed, and their metabolic pathways were optimized to increase L-homoserine production.

Benefits of technology

The yield of L-homoserine was increased by 43% in shake flasks and by 72.2% in 5L fermenters, achieving efficient and economical L-homoserine production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The invention discloses a recombinant genetically engineered bacterium for producing L-homoserine at high yield and application of the recombinant genetically engineered bacterium. L-homoserine transporter with higher efficiency is obtained by editing, superposing and screening multiple genes, and the yield of L-homoserine is further increased by overexpressing thrE gene; and screening to obtain the recombinant genetically engineered bacterium capable of improving the yield of the L-homoserine. The yield of the L-homoserine in a shake flask reaches 5.62 g / L, and compared with a control strain, the yield of the L-homoserine is improved by 43%; the yield of the L-homoserine in a 5L fermentation tank reaches 30.9 g / L within 72 hours, and compared with a control strain, the yield of the L-homoserine is improved by 72.2%.
Need to check novelty before this filing date? Find Prior Art

Description

(I) Technical Field

[0001] This invention relates to a recombinant genetically engineered bacterium that produces high levels of L-homoserine and its applications. (II) Background Technology

[0002] L-homoserine (L-HS), also known as S-2-amino-4-hydroxybutyric acid, is a non-essential amino acid belonging to the aspartic acid family. It is an important precursor for the synthesis of sulfur-containing compounds such as L-threonine, L-methionine, and L-isoleucine, and has applications in medicine, food, and chemical industries. Furthermore, its derivatives (O-succinyl-L-homoserine and O-acetyl-L-homoserine) can be converted to methionine by highly efficient thiolases, providing an attractive alternative for the large-scale industrial production of methionine.

[0003] The main methods for producing L-homoserine are chemical synthesis, enzymatic synthesis, and microbial fermentation. Chemical synthesis is limited in scale and application due to expensive reagents, low efficiency, and cumbersome purification processes. Enzymatic synthesis requires expensive coenzymes and toxic chemical reagents, restricting its industrial production. Microbial fermentation, however, offers advantages such as low cost, low pollution, and mild, easily controllable conditions for L-homoserine production. In recent years, with the development of synthetic biology, significant efforts have been made in microbial cell factory engineering to efficiently and economically produce L-homoserine, making it a promising alternative to chemical synthesis.

[0004] The metabolic pathway from glucose to L-homoserine begins with glycolysis, where glucose is broken down into pyruvate. The process involves glucose being catalyzed by hexokinase to produce glucose-6-phosphate. Glucose-6-phosphate then undergoes isomerization, phosphorylation, and cleavage reactions under the catalysis of various enzymes, converting to phosphoenolpyruvate. Phosphoenolpyruvate is then converted back to pyruvate under the catalysis of pyruvate kinase. Pyruvate is then converted to oxaloacetate by pyruvate carboxylase. Oxaloacetate is then converted to L-aspartate by aspartate transaminase. Aspartate is phosphorylated to aspartyl-4-phosphate by aspartate kinase, then to aspartate-4-hemialdehyde by aspartate semialdehyde dehydrogenase, and finally reduced to L-homoserine by homoserine dehydrogenase. This pathway is subject to feedback regulation by end products such as lysine and threonine, and is a core branch node in the synthesis of aspartic acid group amino acids.

[0005] Research on the microbial production of L-homoserine mainly focuses on Escherichia coli (E. coli) Escherichia coli The strain is a chassis strain, but requires additional purification steps to remove E. coli endotoxins. However, *Corynebacterium glutamicum* (…) Corynebacterium glutamicumThese steps can be avoided, resulting in higher safety and non-pathogenicity to humans and animals. Furthermore, *Corynebacterium glutamicum* can utilize relatively inexpensive substrates during fermentation, making it suitable for amino acid synthesis. It has been used to produce various amino acids and important compounds, possessing significant research value. Currently, *Corynebacterium glutamicum* is used not only for the production of L-glutamic acid but also for the production of L-alanine, L-lysine, L-threonine, L-methionine, and other amino acids. However, research on the fermentation of L-homoserine using *Corynebacterium glutamicum* is limited. Therefore, modifying *Corynebacterium glutamicum* using metabolic engineering strategies to improve its L-homoserine production capacity is of significant value.

[0006] Regarding product efflux, although studies have reported on transport proteins... BrnFE Its application in increasing L-homoserine production has shown a positive effect, suggesting the possible existence of other unexplored L-homoserine transporters within microbial cells. These potential transporters may possess higher transport efficiency and broader substrate specificity, which would be crucial for further improving L-homoserine production efficiency. (III) Summary of the Invention

[0007] The purpose of this invention is to provide a recombinant genetically engineered bacterium that produces high levels of L-homoserine and its applications. Through multiple gene editing and screening, a more efficient L-homoserine transporter protein is obtained, thereby further increasing the yield of L-homoserine.

[0008] The technical solution adopted in this invention is:

[0009] In a first aspect, the present invention provides a recombinant genetically engineered bacterium that produces high levels of L-homoserine, wherein the recombinant genetically engineered bacterium uses Corynebacterium glutamicum ATCC13032 as the starting strain and performs one or more of the following gene edits on the genome of the starting strain: hom Gene, asd Gene, aspB Gene, PPC Gene, pyk1 Gene pyk2 The original promoter of the gene is replaced with P tuf The promoter will lysC The original gene promoter was replaced with P tuf The promoter and its encoded protein's threonine residue position 311 is replaced with isoleucine. dapA Gene, icd Gene, gltA The start codon ATG of the gene is replaced with GTG, and the gene is knocked out. metX Gene, knockout thrB Gene, knockout aspA Gene, knockout pckGenes, overexpression thrE Gene.

[0010] Furthermore, the aforementioned hom The nucleotide sequence of the gene is shown in Gene ID: 1019166; asd The nucleotide sequence of the gene is shown in Gene ID: 1021315; lysC The nucleotide sequence of the gene is shown in Gene ID: 1021294; dapA The nucleotide sequence of the gene is shown in Gene ID: 1019928; metX The nucleotide sequence of the gene is shown in GeneID: 1018653; thrB The nucleotide sequence of the gene is shown in Gene ID: 1019167; aspA The nucleotide sequence of the gene is shown in Gene ID: 1019476; aspB The nucleotide sequence of the gene is shown in Gene ID: 1021066; icd The nucleotide sequence of the gene is shown in Gene ID: 1018663; gltA The nucleotide sequence of the gene is shown in Gene ID: 1018824; PPC The nucleotide sequence of the gene is shown in Gene ID: 1019553; pck The nucleotide sequence of the gene is shown in Gene ID:1020806; pyk1 The nucleotide sequence of the gene is shown in Gene ID:1020040; pyk2 The nucleotide sequence of the gene is as shown in SEQ ID NO.1; the P tuf The nucleotide sequence of the promoter is shown in SEQ ID NO.2; thrE The nucleotide sequence of the gene is shown in Gene ID: 1020569.

[0011] Furthermore, the recombinant genetically engineered bacteria, using Corynebacterium glutamicum ATCC13032 as the starting strain, underwent the following gene editing sequentially: hom , asd , lysC, aspB, ppc, pyk1, pyk2 The original gene promoter was replaced with P tuf Promoters enhance their expression; lysC Replace the threonine residue at position 311 of the gene-encoded protein with isoleucine; dapA, icd, gltA Replacing the ATG start codon with GTG weakens gene expression; knockout metX Gene, thrB Gene, aspA Gene, pck Gene; overexpressed on plasmid pEC-xk99E thrE Gene.

[0012] Furthermore, the recombinant genetically engineered bacteria are constructed according to the following steps:

[0013] (1) Using Corynebacterium glutamicum ATCC13032 as the starting strain, the pK19mobsacB shuttle plasmid was used to... hom , asd , lysC The original promoter of the gene is replaced with P tuf (2) Based on strain cgH-1, the promoter was used to construct strain cgH-1; lysC The threonine at position 311 of the gene-encoded protein was replaced with isoleucine to construct strain cgH-2; (3) Based on strain cgH-2, dapA The gene start codon ATG was replaced with GTG to weaken its expression, and strain cgH-3 was constructed; (4) Based on strain cgH-3, the gene was knocked out metX Genes were used to reduce the accumulation of methionine, and strain cgH-4 was constructed; (5) Based on strain cgH-4, the gene was knocked out. thrB Gene, construct strain cgH-5; (6) Based on strain cgH-5, knock out aspA Gene, construct strain cgH-6; (7) Based on strain cgH-6, aspB The original gene promoter was replaced with P tuf Promoter, construct strain cgH-7; (8) Based on strain cgH-7, icd The start codon ATG was replaced with GTG to construct strain cgH-8; (9) Based on strain cgH-8, gltA The start codon ATG was replaced with GTG to construct strain cgH-9; (10) Based on strain cgH-9, PPC The original gene promoter was replaced with P tuf Promoter, construct strain cgH-10; (11) Based on strain cgH-10, knock out pck Genes, construct strain cgH-11; (12) Based on strain cgH-11, pyk1 The original gene promoter was replaced with P tuf Promoter, construct strain cgH-12; (13) Based on strain cgH-12, pyk2 The original gene promoter was replaced with P tuf Promoter, construct strain cgH-13; (14) Based on strain cgH-13, overexpress on plasmid pEC-xk99E. thrE Genes were used to construct strain cgH-14.

[0014] Secondly, the present invention provides an application of the recombinant genetically engineered bacteria in the fermentation preparation of L-homoserine.

[0015] Further, the fermentation is carried out in a shake flask according to the following steps: the recombinant genetically engineered bacteria in the glycerol tube are streaked on LB agar plates (LB contains 25 mg / L kanamycin if carrying the pEC-xk99E plasmid) and cultured at 30 ℃ for 48 h to obtain single colonies; single colonies from the plate are picked and inoculated into LB medium (LB contains 25 mg / L kanamycin if carrying the pEC-xk99E plasmid) and cultured at 30 ℃ and 200-220 rpm for 14-16 h to obtain primary seed culture; the primary seed culture is inoculated into seed medium at a volume concentration of 1% and cultured at 30 ℃ and 200-220 rpm for 12 h to obtain secondary seed culture; the secondary seed culture is inoculated into fermentation medium at a volume concentration of 5% (fermentation medium contains 25 mg / L kanamycin if carrying the pEC-xk99E plasmid) and cultured for another 48 h. The fermentation process continues until the end of h, yielding a fermentation broth containing L-homoserine. The fermentation broth is then separated and purified to obtain L-homoserine.

[0016] The seed culture medium consists of: 25 g / L glucose, 1.25 g / L urea, 4 g / L yeast extract, 1 g / L potassium dihydrogen phosphate, 0.5 g / L magnesium sulfate heptahydrate, 0.5 g / L threonine, 0.5 g / L methionine, with water as the solvent and pH 7.0.

[0017] The fermentation medium consisted of: glucose 50 g / L, yeast extract 4 g / L, ammonium sulfate 20 g / L, potassium dihydrogen phosphate 1 g / L, magnesium sulfate heptahydrate 0.5 g / L, manganese sulfate monohydrate 0.01 g / L, ferrous sulfate heptahydrate 0.01 g / L, vitamin B1 1 mg / L, vitamin B6 6 mg / L, biotin 0.025 mg / L, and vitamin B... 12 0.2 g / L, threonine 0.5 g / L, methionine 0.5 g / L, pH adjusted to 7.0 with CaCO3, sterilized at 115℃ for 30 min.

[0018] Further, the fermentation is carried out in a fermenter according to the following steps: the recombinant genetically engineered bacteria in the glycerol tube are streaked onto LB agar plates (LB contains 25 mg / L kanamycin if carrying the pEC-xk99E plasmid) and cultured at 30°C for 48 h to obtain single colonies; single colonies from the plate are picked and inoculated into LB medium (LB contains 25 mg / L kanamycin if carrying the pEC-xk99E plasmid) and cultured at 30°C and 200-220 rpm for 14-16 h to obtain primary seed culture; the primary seed culture is inoculated into seed medium at a volume concentration of 5% and cultured at 30°C and 200-220 rpm for 12 h to obtain secondary seed culture; the secondary seed culture is inoculated into fermentation medium (LB contains 25 mg / L kanamycin if carrying the pEC-xk99E plasmid) at a volume concentration of 10% In a 5L fermenter containing 1 mg / L kanamycin, fermentation was carried out at 30℃, 300-900 rpm, and an aeration rate of 2 V / V / min. When the pH was higher than 7.2 (the initial sugar in the fermenter was consumed), automatic feeding was started, and feeding was stopped when the pH was lower than 7.2. The culture was incubated for 76 h to obtain a fermentation broth containing L-homoserine. The fermentation medium composition in the 5L fermenter was: glucose 90 g / L, corn steep liquor 10 g / L, yeast extract 5 g / L, ammonium sulfate 8 g / L, dipotassium hydrogen phosphate 4 g / L, magnesium sulfate heptahydrate 4 g / L, ferrous sulfate heptahydrate 1.5 g / L, manganese sulfate monohydrate 50 mg / L, zinc sulfate heptahydrate 20 mg / L, copper sulfate 20 mg / L, VB1, VB3, VB5, VB6, VB 12 Each of the following ingredients was added at a concentration of 10 mg / L: biotin 0.5 mg / L, threonine 2 g / L, and methionine 1 g / L. The solvent was water, and the pH was adjusted to 7.2 with 60% ammonia. The feed culture medium consisted of: 600 g / L glucose, 40 g / L ammonium sulfate, 2 g / L threonine, and 1 g / L methionine. The solvent was water, and the pH was adjusted to 7.2 with 60% ammonia.

[0019] Furthermore, the feeding rate is 23~36 mL / h, and the total amount of feeding culture medium added is 1500 mL / 2L.

[0020] Compared with the prior art, the beneficial effects of the present invention are mainly reflected in:

[0021] This invention, through multiple gene editing stacking and screening, yielded a more efficient L-homoserine transporter, which was then overexpressed. thrEGenes were used to further increase L-homoserine production, and recombinant genetically engineered bacteria capable of increasing L-homoserine production were screened. In shake flasks, L-homoserine production reached 5.62 g / L, a 43% increase compared to the control strain; in a 5L fermenter, L-homoserine production reached 30.9 g / L after 72 h, a 72.2% increase compared to the control strain. (iv) Description of the attached drawings

[0022] Figure 1 This is a diagram of the L-homoserine metabolic pathway.

[0023] Figure 2 Biomass OD of wild-type strains and strains cgH-1 to cgH-6 600 A bar chart of L-homoserine concentration.

[0024] Figure 3 The biomass OD of strains cgH-6~cgH-13 600 A bar chart of L-homoserine concentration.

[0025] Figure 4 The biomass OD of strains cgH-13~cgH-14 600 A bar chart of L-homoserine concentration.

[0026] Figure 5 The biomass OD of strain cgH-13 during fed-batch fermentation in a 5-L fermenter 600 Concentration curves of residual sugar and L-homoserine.

[0027] Figure 6 Biomass OD of strain cgH-14 in a 5-L feed fermenter 600 Concentration curves of residual sugar and L-homoserine. (V) Detailed Implementation Methods

[0028] The present invention will be further described below with reference to specific embodiments, but the scope of protection of the present invention is not limited thereto:

[0029] In this embodiment of the invention, Corynebacterium glutamicum ( C. glutamicum ATCC13032 was the starting strain, denoted as strain W, and was preserved in our laboratory. All synthetic genes in this invention were synthesized by Beijing Qingke Biotechnology Co., Ltd. Gene fragment ligation was performed using a non-ligase-dependent single-fragment rapid cloning kit (ClonExpress® One step clonekit, Vazyme Biotech, Nanjing, China).

[0030] LB plate composition: 10 g / L peptone, 5 g / L yeast extract, 10 g / L NaCl, 15 g / L agar powder, water as solvent, natural pH.

[0031] LB medium composition: 10 g / L peptone, 5 g / L yeast extract, 10 g / L NaCl, solvent is deionized water, pH value is natural.

[0032] The seed culture medium formula is as follows: glucose 25 g / L, urea 1.25 g / L, yeast extract 4 g / L, potassium dihydrogen phosphate 1 g / L, magnesium sulfate heptahydrate 0.5 g / L, threonine 0.5 g / L, methionine 0.5 g / L, water as solvent, pH 7.0.

[0033] The fermentation medium formula used for shake-flask fermentation is as follows: glucose 50 g / L, yeast extract 4 g / L, ammonium sulfate 20 g / L, potassium dihydrogen phosphate 1 g / L, magnesium sulfate heptahydrate 0.5 g / L, manganese sulfate monohydrate 0.01 g / L, ferrous sulfate heptahydrate 0.01 g / L, vitamin B1 1 mg / L, vitamin B6 6 mg / L, biotin 0.025 mg / L, vitamin B... 12 0.2 g / L, threonine 0.5 g / L, methionine 0.5 g / L, water as solvent, pH adjusted to 7.0 with CaCO3, sterilized at 115℃ for 30 min.

[0034] Table 1 Primers used in the editing process

[0035]

[0036] Example 1: Construction of strain cgH-1

[0037] Homoserine dehydrogenase (HDH) catalyzes the reduction of aspartate-β-semialdehyde (ASA) to L-homoserine, consuming NADPH, and is a direct precursor enzyme in the synthesis of L-homoserine and L-threonine. Aspartate-semialdehyde dehydrogenase (ASD) catalyzes ASA and is a node in the lysine, threonine, and homoserine branches. Aspartate kinase (AK) catalyzes the first step in the aspartate amino acid synthesis pathway, phosphorylating L-aspartate to 4-phosphate-L-aspartate, consuming ATP. Therefore, in this embodiment, the following steps are performed sequentially on the genome of Corynebacterium glutamicum ATCC13032. hom Gene (Gene ID: 1019166) asdGene (Gene ID: 1021315) lysC The original promoter of gene (Gene ID: 1021294) was replaced with the strong promoter P. tuf Enhanced expression, construction of strain cgH-1 (P tuf - hom P tuf - asd P tuf - lysC ).

[0038] 1. Strains ATCC13032 / P tuf - hom Construction

[0039] (1) Construction of pK19mobsacB-line plasmid: According to the reaction system in Table 2, the pK19mobsacB shuttle plasmid was double digested with HindIII and EcoRI. After reacting at 37℃ for 1 h, a plasmid backbone with sticky ends and homologous regions at both ends was obtained.

[0040] Table 2 Reaction System

[0041]

[0042] The enzyme digestion products were placed in a 75°C oven for 30 min to inactivate them. Then, the undigested pK19mobsacB plasmid and the inactivated enzyme digestion products were detected by agarose gel electrophoresis. The linear plasmid moved slower than the circular plasmid in agarose gel electrophoresis, thus obtaining the linearized vector pK19mobsacB-line.

[0043] (2) Construct pK19-P tuf - hom plasmid: according to hom Primers were designed based on gene sequences (Table 1) to... hom -up-F / hom Using primers -up-R and the genome of Corynebacterium glutamicum ATCC13032 as a template, PCR amplification was performed according to the amplification system in Table 3 and the amplification procedure in Table 4. hom Donor-, a gene homologous arm fragment hom ; Synthetic genes optimized with codons tuf Using the nucleotide sequence shown in SEQ ID NO.2 as a template, and with P tuf - hom -F / P tuf - hom -R is a primer, and the strong promoter P is obtained by PCR amplification. tuf Fragment (nucleotide sequence as shown in SEQ ID NO.2); with hom -F / hom -R is the primer, and the genome of Corynebacterium glutamicum ATCC13032 is used as a template for PCR amplification to obtain... hom The gene fragment (nucleotide sequence as shown in Gene ID: 1019166) was then recovered using a Clean up kit for later use. The linearized vector pK19mobsacB-line from step (1) was then used with the ClonExpress® One stepclone kit. hom Donor-, a gene homologous arm fragment hom Strong promoter P tuf Fragments hom Gene fragments are linked together, and the ligation product is transformed into... E. coli DH5α competent cells were plated onto LB agar plates containing 50 mg / L kanamycin and incubated at 37 °C for 12 h. Colony PCR was performed using YZ-pK19-F / YZ-pK19-R primers for verification, and sequencing confirmed the successful construction of a colony containing pK19-P. tuf - hom The strain containing the plasmid.

[0044] Taking the amplification of homologous arms on hom as an example, the PCR amplification system is shown in Table 3, and the PCR amplification program is shown in Table 4.

[0045] SEQ ID NO. 2: aatgtccacagggtagctggtagtttgaaaatcaacgccgttgcccttaggattcagtaa.

[0046] Table 3 PCR Amplification System

[0047]

[0048] Table 4 PCR Amplification Procedure

[0049]

[0050] (3) Transformation plasmid: The plasmid pK19-P tuf -homElectroporation was used to transform *Corynebacterium glutamicum* ATCC 13032 plasmid-free competent cells. The transformed bacterial culture was plated on LB agar plates containing 25 mg / L kanamycin and incubated at 30°C until single colonies appeared. A single colony was picked and incubated on LB agar containing 25 mg / L kanamycin at 30°C and 220 rpm for 14–16 h to obtain a bacterial culture. This culture was then transferred at a 10% (v / v) concentration to LB agar containing 0.05 g / L glucose and incubated at 30°C and 220 rpm for 24 h to obtain a bacterial culture. 2.5 μL of this culture was plated on LB agar plates containing 100 g / L sucrose and incubated at 30°C for 48 h. Single colonies were picked for verification, yielding the correct transformant ATCC13032 / P. tuf - hom .

[0051] 2. Strains ATCC13032 / P tuf - hom / P tuf - asd / P tuf - lysC Construction

[0052] Following the method in step 1, using the genome of Corynebacterium glutamicum ATCC13032 as a template, Donor- was obtained using the primers in Table 1. lysC , lysC Gene fragment (nucleotide sequence as shown in Gene ID: 1021294), then combined with promoter P tuf pK19mobsacB-line connection, constructing a B-line containing lysC The gene plasmid pK19-P tuf - lysC After successful detection, the strain was transformed into the strain from step 1 using electroporation. In the genome, asd Genes located at lysC Downstream of the gene, and asd and lysC The genes are regulated by the same promoter, thus yielding strain ATCC13032 / P. tuf - hom / P tuf - asd / P tuf - lysC It is denoted as strain cgH-1.

[0053] 3. Performance testing of strains in shake-flask fermentation

[0054] CgH-1 from glycerol tubes was streaked onto LB agar plates and incubated overnight at 30°C to obtain single colonies. Single colonies were picked from the plates and inoculated into LB medium, then incubated at 30°C and 180-200 rpm for 14-16 hours to obtain primary seed culture. The primary seed culture was then inoculated into seed medium at a concentration of 1% (v / v) and incubated at 30°C and 200 rpm for 12 hours to obtain secondary seed culture. The secondary seed culture was then inoculated into fermentation medium at a concentration of 5% (v / v) and incubated at 30°C and 220 rpm with shaking for 48 hours. The fermentation broth was centrifuged, and the supernatant was analyzed using a spectrophotometer to measure the optical density (OD) at 600 nm. 600 (i.e., biomass), and take the supernatant as a sample to detect the content of L-homoserine, such as Figure 2 As shown, the wild-type strain did not accumulate L-homoserine; the biomass OD of strain cgH-1 was... 600 The concentration was 28.5, and the L-homoserine content was 0.02 g / L. Compared with wild type, by enhancing expression... hom , asd , lysC This resulted in a slight increase in the production of L-homoserine.

[0055] 4. Determination of L-homoserine concentration

[0056] CNBF derivatization reagent preparation: Dissolve 0.189 g of 4-nitro-3,5-dinitrotricyanotoluene in 10 ml of acetonitrile.

[0057] Sample preparation: Dilute the sample with ultrapure water to between 0.1-1 g / L.

[0058] Reaction conditions: Take 100 µL of diluted sample into an EP tube, then add 500 µL of pH 9.0, 200 mM boric acid-borax buffer and 300 µL of CNBF derivatization reagent. Incubate the 900 µL reaction system in a metal bath at 60 °C and 400 rpm for 1 h. After the reaction is complete, filter the reaction solution through a 0.22 µm organic filter membrane, and take 300 µL of the filtered sample to store in a memory tube protected from light for later use.

[0059] Detection conditions: The high-performance liquid chromatograph (HPLC) was an Agilent 1260 Infinity II, and the column was a J&K Scientific HPLC C18-H column (4.6 × 250 mm, 5 μm). Mobile phase A: pure acetonitrile; Mobile phase B: acetonitrile: ultrapure water: triethylamine: acetic acid (83:17:0.2:0.3, v / v / v / v). The flow rate was set at 0.8 mL / min, the column temperature at 30℃, the detection wavelength at 260 nm, and the injection volume at 10 µL. The gradient elution program is shown in Table 5.

[0060] Table 5. High-performance liquid chromatography elution program for L-homoserine

[0061]

[0062] Example 2: Construction of strain cgH-2

[0063] Aspartate kinase is a total carbon flux control point in the pathway because it is subject to synergistic feedback inhibition by the end products L-lysine, L-threonine, and L-methionine. The aspartate kinase encoding gene... lysC Mutation and screening laid the foundation for the efficient fermentation production of L-homoserine and other downstream aspartic acid family metabolites. Therefore, this example involves site-directed mutagenesis on strain cgH-1. lysC Genes (nucleotide sequences shown in Gene ID: 1021294) were used to construct strain cgH-2 by replacing the threonine at position 311 of the aspartate kinase with isoleucine. tuf - hom / P tuf - asd / P tuf - lysC T311I ).

[0064] With plasmid P tuf - lysC Using as a template, lysC -TB-F / lysC Using TB-R as primers, site-directed mutagenesis was performed by PCR. The PCR product was digested with Dpn I and incubated at 37 °C for 2 h to remove methylation vectors. The DNA fragment was then recovered using a Clean Up kit. Following the method in Example 1, the recovered DNA fragment was ligated into the linearized plasmid pK19mobsacB-line using the ClonExpress® One step clone kit and verified, yielding pK19- lysC T311I Plasmid. The plasmid pK19- lysC T311I The cgH-2 strain was obtained by electroporation into competent cells of the cgH-1 plasmid-free strain.

[0065] Using cgH-1 as the control strain, strain cgH-2 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 2 As shown, the biomass OD of strain cgH-1 600 The concentration was 28.5, and the L-homoserine content was 0.02 g / L; the biomass OD of strain cgH-2 was 28.5. 600The concentration was 25.2, and the L-homoserine content was 0.053 g / L, indicating that the aspartate kinase encoding gene... lysC Mutation and screening yielded an aspartate kinase mutant with enhanced catalytic activity, resulting in an approximately 2-fold increase in L-homoserine production.

[0066] Example 3: Construction of strain cgH-3

[0067] dapA The gene encodes dihydrodipicolinate synthase (DHDPS), the rate-limiting enzyme in the lysine biosynthesis pathway. Its rate can be reduced by site-directed mutagenesis of the start codon. dapA This reduces the expression level, which in turn helps decrease the accumulation of L-lysine byproducts. Therefore, this example demonstrates the weakening of expression levels on strain cgH-2. dapA Gene (nucleotide sequence as shown in Gene ID: 1019928), with the start codon ATG replaced by GTG, to construct strain cgH-3 (P tuf - hom / P tuf - asd / P tuf - lysC T311I / dapA M1V ).

[0068] Using the genome of Corynebacterium glutamicum ATCC13032 as a template, according to dapA Gene sequence design primers, to dapA -F / dapA -R indicates that primers amplify the product containing Donor. dapA The gene fragment (nucleotide sequence as shown in Gene ID: 1019928) was used to obtain pK19- using the method in Example 2. dapA M1V Plasmid. The plasmid pK19- dapA M1V The cgH-3 strain was obtained by electroporation into competent cells of the cgH-2 plasmid-free strain.

[0069] Using strain cgH-2 as the control, strain cgH-3 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 2 As shown, the biomass OD of the control strain cgH-2 600 The OD value of strain cgH-3 was 25.2, with an L-homoserine content of 0.053 g / L; 600 The value was 29.5, and the L-homoserine content was 0.068 g / L, indicating a weakening effect. dapA The gene reduced the accumulation of lysine, thereby increasing the production of L-homoserine by 28.3%.

[0070] Example 4: Construction of strain cgH-4

[0071] metX The gene encodes homoserine O-acetyltransferase (HAT), a key initiating enzyme in the methionine synthesis pathway. Knockout metX The gene can reduce the accumulation of methionine. Knockout in strain cgH-3 metX Gene (nucleotide sequence as shown in Gene ID: 1018653), construct strain cgH-4 (P tuf - hom / P tuf - asd / P tuf - lysC T311I / dapA M1V / Δ metX ).

[0072] Using the genome of Corynebacterium glutamicum ATCC13032 as a template, according to metX Gene sequence design primers, to metX -up-F / metX -up-R、 metX -down-F / metX -down-R is the primer amplification to obtain Donor- metX -1、Donor- metX -2 fragments, using the method of Example 1, to Donor- metX -1、Donor- metX -2 fragments are concatenated with pK19mobsacB-line to obtain pK19- metX Plasmid. The plasmid pK19- metX The cgH-4 strain was obtained by electroporation into competent cells of the cgH-3 plasmid-free strain.

[0073] Using strain cgH-3 as the control, strain cgH-4 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 2 As shown, the biomass OD of the control strain cgH-3 600 The concentration was 29.5, and the L-homoserine content was 0.068 g / L; the biomass OD of strain cgH-4 was 29.5. 600 The content of L-homoserine was 0.54 g / L, which was 20, an increase of nearly 9 times.

[0074] Example 5: Construction of strain cgH-5

[0075] thrB The gene encodes homoserine kinase (HSK), a key enzyme in the aspartic acid family amino acid synthesis pathway, a necessary step in the synthesis of L-threonine and L-isoleucine. Therefore, in this embodiment, the gene was knocked out in strain cgH-4. thrB Gene (nucleotide sequence as shown in Gene ID: 1019167), construct strain cgH-5 (P tuf - hom / P tuf - asd / P tuf - lysC T311I / dapA M1V / Δ metX / Δ thrB ).

[0076] Using the genome of Corynebacterium glutamicum ATCC13032 as a template, according to thrB Gene sequence design primers, to thrB -up-F / thrB -up-R、 thrB- down-F / thrB -down-R is the primer amplification to obtain Donor- thrB -1、Donor- thrB -2 fragments, using the method of Example 1, to Donor- thrB -1、Donor- thrB -2 fragments were ligated with the linearized plasmid pK19mobsacB-line to obtain pK19- thrB Plasmid. The plasmid pK19- thrB The cgH-5 strain was obtained by electroporation into competent cells of the cgH-4 plasmid-free strain.

[0077] Using strain cgH-4 as the control, strain cgH-5 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 2 As shown, the biomass OD of the control strain cgH-4 600 The concentration of L-homoserine was 0.54 g / L; the biomass OD of strain cgH-5 was 20. 600 The concentration was 26.1, and the L-homoserine content was 1.18 g / L, which was approximately twice that of the control strain. (Knockout) thrBThe gene reduced the accumulation of L-threonine and L-isoleucine, and increased the production of L-homoserine.

[0078] Example 6: Construction of strain cgH-6

[0079] aspA The gene encodes aspartase, which degrades aspartic acid to provide fumarate for the TCA cycle. Therefore, in this embodiment, the gene was knocked out in strain cgH-5. aspA Gene (nucleotide sequence as shown in Gene ID: 1019476), construct strain cgH-6 (P tuf - hom / P tuf - asd / P tuf - lysC T311I / dapA M1V / Δ metX / Δ thrB / Δ aspA ).

[0080] Using the genome of Corynebacterium glutamicum ATCC13032 as a template, according to aspA Gene sequence design primers, to aspA -up-F / aspA -up-R、 aspA- down-F / aspA -down-R is the primer amplification to obtain Donor- aspA -1、Donor- aspA -2 fragments, using the method of Example 1, to Donor- aspA -1、Donor- aspA -2 fragments were ligated with the linearized plasmid pK19mobsacB-line to obtain pK19- aspA Plasmid. The plasmid pK19- aspA The cgH-6 strain was obtained by electroporation into competent cells of the cgH-5 plasmid-free strain.

[0081] Using strain cgH-5 as the control, strain cgH-6 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 2 As shown, the biomass OD of the control strain cgH-5 600 The OD value of strain cgH-6 was 26.1, with an L-homoserine content of 1.18 g / L; 600 The concentration of L-homoserine was 27.1 g / L, and the content of L-homoserine was 1.49 g / L, which increased the yield of L-homoserine by 26% compared with the control.

[0082] Example 7: Construction of strain cgH-7

[0083] aspB The gene encodes aspartate aminotransferase (AAT), which converts the central carbon metabolite oxaloacetate (OAA) into L-aspartic acid, serving as the starting point for the synthesis of L-lysine, L-homoserine, L-threonine, and other products. Therefore, in this example, the gene was used on strain cgH-6... aspB The original promoter of the gene (nucleotide sequence as shown in Gene ID: 1021066) was replaced with the strong promoter P. tuf Enhanced expression, constructing strain cgH-7 (P tuf - hom / P tuf - asd / P tuf - lysC T311I / dapA M1V / Δ metX / Δ thrB / Δ aspA / P tuf -aspB ).

[0084] Using the genome of Corynebacterium glutamicum ATCC13032 as a template, according to aspB Gene sequence design primers, to aspB -up-F / aspB -up-R、 aspB -F / aspB -R is the primer for amplifying Donor- aspB and aspB Gene fragments, using the method in Example 1, were used to extract Donor- aspB and aspB Gene fragments and promoter P tuf Linearized plasmid pK19mobsacB-line was ligated to obtain pK19- containing Donor. P tuf -aspB Plasmid. The plasmid pK19- P tuf -aspB The cgH-7 strain was obtained by electroporation into competent cells of the cgH-6 plasmid-free strain.

[0085] Using strain cgH-6 as the control, strain cgH-7 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 3 As shown, the biomass OD of the control strain cgH-6600 The OD value of strain cgH-7 was 27.1, with an L-homoserine content of 1.49 g / L. 600 The value was 28.4, and the L-homoserine content was 1.65 g / L, which was 10.7% higher than the control, indicating overexpression. aspB It promotes the entry of carbon flows into the biosynthetic pathway of L-aspartic acid family amino acids.

[0086] Example 8: Construction of strain cgH-8

[0087] icd The gene encodes isocitrate dehydrogenase, which catalyzes the conversion of isocitrate to α-ketoglutarate. Therefore, in this example, strain cgH-7 will... icd The start codon ATG of the gene (nucleotide sequence as shown in Gene ID: 1018663) was replaced with GTG for attenuated expression, and strain cgH-8 (P) was constructed. tuf - hom / P tuf - asd / P tuf - lysC T311I / dapA M1V / Δ metX / Δ thrB / Δ aspA / P tuf -aspB / icd M1V ).

[0088] Using the genome of Corynebacterium glutamicum ATCC13032 as a template, according to icd Gene sequence design primers, to icd -F / icd -R indicates that primers amplify the product containing Donor. icd Gene fragments were obtained using the method described in Example 2, resulting in pK19- icd M1V Plasmid. The plasmid pK19- icd M1V The cgH-8 strain was obtained by electroporation into competent cells of the cgH-7 plasmid-free strain.

[0089] Using strain cgH-7 as the control, strain cgH-8 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 3 As shown, the biomass OD of the control strain cgH-7 600 The OD value of strain cgH-8 was 28.4, with an L-homoserine content of 1.65 g / L; the biomass OD of strain cgH-8 was... 600The concentration was 24.7, and the L-homoserine content was 2.28 g / L, an increase of 38.1% compared to the control, indicating a weakening effect. icd The production of α-ketoglutarate decreases, while the accumulation of OAA increases through the complementation reaction, thereby raising the level of aspartic acid and providing more precursors for the synthesis of L-homoserine.

[0090] Example 9: Construction of strain cgH-9

[0091] gltA The gene encodes citrate synthase, an enzyme that catalyzes the condensation of oxaloacetate and acetyl-CoA to produce citrate. Therefore, this example demonstrates the application of cgH-8 strain... gltA The start codon ATG of the gene (nucleotide sequence as shown in Gene ID: 1018824) was replaced with GTG for attenuated expression, and strain cgH-9 (P) was constructed. tuf - hom / P tuf - asd / P tuf - lysC T311I / dapA M1V / Δ metX / Δ thrB / Δ aspA / P tuf -aspB / icd M1V / gltA M1V ).

[0092] Using the genome of Corynebacterium glutamicum ATCC13032 as a template, according to gltA Gene sequence design primers, to gtlA -F / gtlA -R indicates that primers amplify the product containing Donor. gltA Gene fragments were obtained using the method described in Example 2, resulting in pK19- gltA M1V Plasmid. The plasmid pK19- gltA M1V The cgH-9 strain was obtained by electroporation into competent cells of the cgH-8 plasmid-free strain.

[0093] Using strain cgH-8 as the control, strain cgH-9 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 3 As shown, the biomass OD of the control strain cgH-8 600 The OD value of strain cgH-9 was 24.7, with an L-homoserine content of 2.28 g / L. 600The concentration of L-homoserine was 22.3 g / L, and the content of L-homoserine was 2.31 g / L. Compared with the control, the yield of L-homoserine was slightly increased.

[0094] Example 10: Construction of strain cgH-10

[0095] ppc The gene encodes phosphoenolpyruvate carboxylase (PPC), which catalyzes the reaction in which phosphoenolpyruvate (PEP) combines with carbon dioxide to form oxaloacetic acid (OAA). Therefore, in this example, on strain cgH-9... ppc The original promoter of the gene (nucleotide sequence as shown in Gene ID: 1019553) was replaced with a strong promoter. P tuf Enhanced expression, construction of strain cgH-10 (P tuf - hom / P tuf - asd / P tuf - lysC T311I / dapA M1V / Δ metX / Δ thrB / Δ aspA / P tuf -aspB / icd M1V / gltA M1V / P tuf -ppc ).

[0096] Using the genome of Corynebacterium glutamicum ATCC13032 as a template, according to ppc Gene sequence design primers, to ppc -up-F / ppc -up-R、 ppc -F / ppc -R is the primer for amplifying Donor- ppc upper homologous arm and ppc Gene fragments, using the method in Example 1, were used to extract Donor- ppc upper homologous arm and ppc Gene fragments and promoter P tuf Linearized plasmid pK19mobsacB-line was ligated to obtain pK19- containing Donor. P tuf -ppc Plasmid. The plasmid pK19- P tuf -ppcThe cgH-10 strain was obtained by electroporation into competent cells of the cgH-9 plasmid-free strain.

[0097] Using strain cgH-9 as the control, strain cgH-10 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 3 As shown, the biomass OD of the control strain cgH-9 600 The OD value of strain cgH-10 was 22.3, with an L-homoserine content of 2.31 g / L. 600 The L-homoserine content was 2.66 g / L, representing a 15% increase in L-homoserine production compared to the control, indicating overexpression. ppc The gene increases the expression of PEP carboxylase and oxaloacetate, providing more precursors for the synthesis of L-homoserine.

[0098] Example 11: Construction of strain cgH-11

[0099] Phosphoenolpyruvate carboxykinase (PCK) is composed of... pck The gene encodes a key metabolic enzyme that catalyzes the decarboxylation of oxaloacetic acid (OAA) to phosphoenolpyruvate. Therefore, in this embodiment, the enzyme is knocked out in strain cgH-10. pck Gene (nucleotide sequence as shown in Gene ID: 1020806), construct strain cgH-11 (P tuf - hom / P tuf - asd / P tuf - lysC T311I / dapA M1V / Δ metX / Δ thrB / Δ aspA / P tuf -aspB / icd M1V / gltA M1V / P tuf -ppc / Δ pck ).

[0100] Using the genome of Corynebacterium glutamicum ATCC13032 as a template, according to pck Gene sequence design primers, to pck -up-F / pck -up-R、 pck- down-F / pck -down-R is the primer amplification to obtain Donor- pck -1、Donor- pck -2 fragments, using the method of Example 1, to Donor- pck -1、Donor- pck -2 fragments were ligated with the linearized plasmid pK19mobsacB-line to obtain pK19- pck Plasmid. The plasmid pK19- pck The cgH-11 strain was obtained by electroporation into competent cells of the cgH-10 plasmid-free strain.

[0101] Using strain cgH-10 as the control, strain cgH-11 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 3 As shown, the biomass OD of the control strain cgH-10 600 The OD200 of strain cgH-11 was 25.6 g / L, with an L-homoserine content of 2.66 g / L. 600 The concentration was 21.1, and the L-homoserine content was 3.44 g / L. pck The deficiency may provide more precursors for aspartic acid synthesis by increasing oxaloacetate accumulation, thus increasing L-homoserine production by 29.3% compared to the control.

[0102] Example 12: Construction of strain cgH-12

[0103] Pyruvate kinase (PYK) is a key enzyme in the glycolysis pathway, catalyzing the conversion of phosphoenolpyruvate (PEP) to pyruvate, while simultaneously generating ATP. It is classified into different types based on isoenzymes or isomers. pyk1 and pyk2 Therefore, in this embodiment, strain cgH-11 will... pyk1 The original promoter of the gene (nucleotide sequence as shown in Gene ID: 1020040) is replaced with a strong promoter. P tuf Enhanced expression, constructing strain cgH-12 (P tuf - hom / P tuf - asd / P tuf - lysC T311I / dapA M1V / Δ metX / Δ thrB / Δ aspA / P tuf -aspB / icdM1V / gltA M1V / P tuf -ppc / Δ pck / P tuf -pyk1 ).

[0104] Using the genome of Corynebacterium glutamicum ATCC13032 as a template, according to pyk1 Gene sequence design primers, to pyk1 -up-F / pyk1 -up-R、 pyk1 -F / pyk1 -R is the primer for amplifying Donor- pyk1 and pyk1 Gene fragments, using the method in Example 1, were used to extract Donor- pyk1 and pyk1 Gene fragments and promoter P tuf Linearized plasmid pK19mobsacB-line was ligated to obtain pK19- containing Donor. P tuf -pyk1 Plasmid. The plasmid pK19- P tuf -pyk1 The cgH-12 strain was obtained by electroporation into competent cells of the cgH-11 plasmid-free strain.

[0105] Using strain cgH-11 as the control, strain cgH-12 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 3 As shown, the biomass OD of the control strain cgH-11 600 The OD value of strain cgH-12 was 21.1, with an L-homoserine content of 3.44 g / L. 600 The concentration of L-homoserine was 20.8 g / L, and the content of L-homoserine was 3.61 g / L, which increased the yield of L-homoserine by 4.9% compared with the control.

[0106] Example 13: Construction of strain cgH-13

[0107] This invention uses strain cgH-12 to... pyk2 The original promoter of the gene (nucleotide sequence as shown in SEQ ID NO.1) was replaced with a strong promoter. P tuf Enhanced expression, constructing strain cgH-13 (P tuf - hom / P tuf - asd / Ptuf - lysC T311I / dapA M1V / Δ metX / Δ thrB / Δ aspA / P tuf -aspB / icd M1V / gltA M1V / P tuf -ppc / Δ pck / P tuf -pyk1 / P tuf -pyk2 ).

[0108] Using the genome of Corynebacterium glutamicum ATCC13032 as a template, according to pyk2 Gene sequence design primers, to pyk2 -up-F / pyk2 -up-R、 pyk2 -F / pyk2 -R is the primer for amplifying Donor- pyk2 and pyk2 Gene fragments, using the method in Example 1, were used to extract Donor- pyk2 and pyk2 Gene fragments and promoter P tuf Linearized plasmid pK19mobsacB-line was ligated to obtain pK19- containing Donor. P tuf -pyk2 Plasmid. The plasmid pK19- P tuf -pyk2 The cgH-13 strain was obtained by electroporation into competent cells of the cgH-12 plasmid-free strain.

[0109] Using strain cgH-12 as the control, strain cgH-13 was subjected to shake-flask fermentation according to the method in Example 1, and the content of L-homoserine and biomass OD were detected. 600 ,like Figure 3 As shown, the biomass OD of the control strain cgH-12 600 The OD value of strain cgH-13 was 20.8, with an L-homoserine content of 3.61 g / L. 600 The concentration of L-homoserine was 20.9 g / L, and the content of L-homoserine was 3.93 g / L, representing an 8.5% increase in L-homoserine production compared to the control. Simultaneously, overexpression... pyk1 Genes and pyk2Genes cause metabolic flux to flow more towards the key branch point of aspartic semialdehyde, thereby increasing L-homoserine production.

[0110] Example 14: Fermentation of strain cgH-13

[0111] Strawberry strain cgH-13 from glycerol tubes was streaked onto LB agar plates and incubated overnight at 30°C to obtain single colonies. Single colonies from the plates were inoculated into LB medium and cultured at 30°C and 200 rpm for 14-16 hours to obtain primary seed culture. The primary seed culture was then inoculated into seed medium at a concentration of 5% (v / v) and cultured at 30°C and 200 rpm for 12 hours to obtain secondary seed culture. The secondary seed culture was then inoculated into a 5L fermenter containing 2L of fermentation medium at a concentration of 10% (v / v). Fermentation was carried out at 30°C, 300-900 rpm, and an aeration rate of 2 V / V / min. When the pH exceeded 7.2 (initial sugars in the fermenter were depleted), automatic feeding was initiated. Feeding medium was added until the pH fell below 7.2, at a feeding rate of 26 mL / h, with a total feed medium volume of 1500 mL / 2L. The fermentation was continued for 76 hours to obtain a fermentation broth containing L-homoserine. Using the method of Example 1, the OD was detected at 72 hours. 600 The value was 136.5, and the L-homoserine content was 17.94 g / L. The fermentation process is shown in the attached table. Figure 5 As shown.

[0112] Fermentation medium formulation for a 5L fermenter: glucose 90 g / L, corn steep liquor 10 g / L, yeast extract 5 g / L, ammonium sulfate 8 g / L, dipotassium hydrogen phosphate 4 g / L, magnesium sulfate heptahydrate 4 g / L, ferrous sulfate heptahydrate 1.5 g / L, manganese sulfate monohydrate 50 mg / L, zinc sulfate heptahydrate 20 mg / L, copper sulfate 20 mg / L, VB1, VB3, VB5, VB6, VB7 12 Each of the following ingredients was added at 10 mg / L: biotin 0.5 mg / L, threonine 2 g / L, and methionine 1 g / L. The solvent was water, and the pH was adjusted to 7.2 with 60% ammonia. The feed medium consisted of: 600 g / L glucose, 40 g / L ammonium sulfate, 2 g / L threonine, and 1 g / L methionine. The solvent was water, and the pH was adjusted to 7.2 with 60% ammonia.

[0113] Example 15: Construction of strain cgH-14 (amino acid transporter encoding gene) thrE (Enhanced Expression)

[0114] ThrE proteins belong to the ThrE family of transport proteins and are multifunctional and important amino acid efflux proteins in Corynebacterium glutamicum. Although initially discovered for its L-threonine efflux function, studies have shown that it has a relatively broad substrate range and exhibits some substrate diversity. Both L-homoserine and L-threonine belong to the aspartic acid family, and L-homoserine is a direct biosynthetic precursor of L-threonine. By making the strain threonine-deficient in the early stages, expression is enhanced. thrE To increase L-homoserine production, this example describes overexpression of L-homoserine using plasmid pEC-xk99E on strain cgH-13. thrE Gene (nucleotide sequence as shown in Gene ID: 1020569) was used to construct strain cgH-14.

[0115] (1) Construction of pEC-xk99E-line plasmid: pEC-xk99E plasmid was double digested with HindIII and XbaI according to the system in Table 6 at 37℃ for 1h to obtain linearized plasmid pEC-xk99E-line with sticky ends and homologous regions at both ends.

[0116] Table 6 Reaction System

[0117]

[0118] The enzyme digestion products were placed in a 75℃ oven for 30 min to inactivate them. Then, the undigested pEC-xk99E plasmid and the enzyme digestion products were detected by agarose gel electrophoresis. The linear plasmids moved slower than the circular plasmids in agarose gel electrophoresis.

[0119] (2) Construct pEC-xk99E- [[ID= plasmid: according to ​ Gene sequence design primers, to ​ -F / ​ -R is the primer, and the genome of Corynebacterium glutamicum ATCC13032 is used as a template for PCR amplification. ​ The fragment (nucleotide sequence as shown in GeneID: 1020569) was then recovered using a Clean Up kit for later use. Following the instructions of ClonExpress® (One stepclone kit, Vazyme Biotech, Nanjing, China), the linearized plasmid pEC-xk99E-line from step (1) was prepared. ​ Gene fragments are linked together, and the ligation product is transformed into... ​DH5α competent cells were plated onto LB agar plates containing 50 mg / L kanamycin and incubated at 37 ℃ for 12 h. Colony PCR was performed using YZ-pEC-F / YZ-pEC-R primers for verification, and sequencing confirmed the successful construction of a colony containing pEC-xk99E-. ​ The strain containing the plasmid.

[0120] (3) Transformation plasmid: The plasmid pEC-xk99E- ​ Electroporation was used to transform the cgH-13 strain into competent cells. The transformed bacterial solution was spread on LB medium containing kanamycin at a final concentration of 25 mg / L and cultured at 30 °C until a single colony grew. A single colony was picked for verification, and the correct strain cgH-14 was obtained.

[0121] (4) Test of shake-flask fermentation performance of plasmid-carrying strains: CgH-14 in glycerol tubes was streaked on LB agar plates (containing 25 mg / L kanamycin) and cultured overnight at 30 °C to obtain single colonies; single colonies from the plates were inoculated into LB medium (containing 25 mg / L kanamycin) and cultured at 30 °C and 200 rpm for 14-16 h to obtain primary seed culture; the primary seed culture was inoculated into seed medium (containing 25 mg / L kanamycin) at a volume concentration of 1% and cultured at 30 °C and 200 rpm for 12 h to obtain secondary seed culture. The secondary seed culture was inoculated into fermentation medium (containing 25 mg / L kanamycin) at a volume concentration of 5% and cultured at 30 °C and 220 rpm until the bacterial cells grew to OD. 600 =30, add 0.2 mM IPTG to a final concentration, and incubate at 30 ℃ and 220 rpm with shaking for 48 h. After centrifugation, the supernatant was analyzed using a spectrophotometer to measure the optical density (OD) at 600 nm. 600 (i.e., biomass), and another sample of the supernatant was used to detect the L-homoserine content, with strain cgH-13 as a control. ​ As shown, the biomass OD of the control strain cgH-13 600 The concentration was 20.9 g / L, the L-homoserine content was 3.93 g / L, and the biomass OD of strain cgH-14 was [missing information]. 600 The concentration of L-homoserine was 25.5 g / L, and the content of L-homoserine was 5.62 g / L, which increased the yield of L-homoserine by 43% compared with the control.

[0122] Table 7. L-homoserine yield from shake-flask fermentation of different genotype strains

[0123]

[0124] Example 16: Fermentation culture of strain cgH-14

[0125] Strawberry strain cgH-14 from glycerol tubes was streaked onto LB agar plates containing 25 mg / L kanamycin and incubated overnight at 30°C to obtain single colonies. Single colonies from the plates were inoculated into LB medium containing 25 mg / L kanamycin and incubated at 30°C and 200 rpm for 14-16 h to obtain primary seed culture. The primary seed culture was then inoculated at a concentration of 5% (v / v) into seed medium containing 25 mg / L kanamycin and incubated at 30°C and 200 rpm for 12 h to obtain secondary seed culture. The secondary seed culture was then inoculated at a concentration of 10% (v / v) into a 5L fermenter containing 2L of fermentation medium containing 25 mg / L kanamycin and fermented at 30°C, 300-900 rpm, and an aeration rate of 2 V / V / min. The culture was then monitored at OD... 600 At pH 30, IPTG was added to a final concentration of 0.2 mM. When the pH was above 7.2 (the initial sugar in the fermenter was consumed), automatic feeding was initiated. Feeding medium was added until the pH fell below 7.2, at which point feeding was stopped. The feeding rate was 23 mL / h, and the total amount of feed medium added was 1500 mL / 2L. The fermentation was carried out for 76 h to obtain a fermentation broth containing L-homoserine. Using the method described in Example 1, the OD was detected at 72 h. 600 The concentration was 122.2, and the L-homoserine content was 30.9 g / L. The fermentation process is shown in [link to fermentation process]. ​ As shown.

[0126] Fermentation medium formulation for a 5L fermenter: glucose 45 g / L, corn steep liquor 5 g / L, yeast extract 2.5 g / L, ammonium sulfate 4 g / L, dipotassium hydrogen phosphate 2 g / L, magnesium sulfate heptahydrate 2 g / L, ferrous sulfate heptahydrate 0.75 g / L, manganese sulfate monohydrate 50 mg / L, zinc sulfate heptahydrate 20 mg / L, copper sulfate 20 mg / L, VB1, VB3, VB5, VB6, VB7 12 Each of the following ingredients was added at 10 mg / L: biotin 0.5 mg / L, kanamycin 25 mg / L, threonine 2 g / L, and methionine 1 g / L. The solvent was water, and the pH was adjusted to 7.2 with 60% ammonia. The feed medium consisted of: glucose 600 g / L, ammonium sulfate 40 g / L, threonine 2 g / L, and methionine 1 g / L. The solvent was water, and the pH was adjusted to 7.2 with 60% ammonia.

Claims

1. A recombinant genetically engineered bacterium that produces high levels of L-homoserine, characterized in that, The recombinant genetically engineered bacteria, using Corynebacterium glutamicum ATCC13032 as the starting strain, underwent one or more of the following gene editing: [editing] on the genome of the starting strain... hom Gene, asd Gene, aspB Gene, PPC Gene, pyk1 Gene pyk2 The original promoter of the gene is replaced with P tuf The promoter will lysC The original gene promoter was replaced with P tuf The promoter and its encoded protein's threonine residue position 311 is replaced with isoleucine. dapA Gene, icd Gene, gltA The start codon ATG of the gene is replaced with GTG, and the gene is knocked out. metX Gene, knockout thrB Gene, knockout aspA Gene, knockout pck Genes, overexpression thrE Gene.

2. The recombinant genetically engineered bacteria as described in claim 1, characterized in that, The P tuf The nucleotide sequence of the promoter is shown in SEQ ID NO.

2.

3. The recombinant genetically engineered bacteria as described in claim 1, characterized in that, The recombinant genetically engineered bacteria, using Corynebacterium glutamicum ATCC13032 as the starting strain, underwent the following gene editing sequentially: hom , asd , lysC, aspB, ppc, pyk1, pyk2 The original gene promoter was replaced with P tuf Promoters enhance its expression; Will lysC Replace the threonine residue at position 311 of the gene-encoded protein with isoleucine; dapA, icd, gltA Replacing the gene start codon ATG with GTG weakens its expression; Knockout metX Gene, thrB Gene, aspA Gene, pck Gene; overexpressed on plasmid pEC-xk99E thrE Gene.

4. The recombinant genetically engineered bacteria as described in claim 3, characterized in that, The recombinant genetically engineered bacteria were constructed according to the following steps: (1) Using Corynebacterium glutamicum ATCC13032 as the starting strain, the pK19mobsacB shuttle plasmid was used to... hom , asd , lysC The original promoter of the gene is replaced with P tuf (2) Based on strain cgH-1, the promoter was used to construct strain cgH-1; lysC The threonine at position 311 of the gene-encoded protein was replaced with isoleucine to construct strain cgH-2; (3) Based on strain cgH-2, dapA The gene start codon ATG was replaced with GTG to weaken its expression, and strain cgH-3 was constructed; (4) Based on strain cgH-3, the gene was knocked out metX Genes were used to reduce the accumulation of methionine, and strain cgH-4 was constructed; (5) Based on strain cgH-4, the gene was knocked out. thrB Gene, construct strain cgH-5; (6) Based on strain cgH-5, knock out aspA Gene, construct strain cgH-6; (7) Based on strain cgH-6, aspB The original gene promoter was replaced with P tuf Promoter, construct strain cgH-7; (8) Based on strain cgH-7, icd The start codon ATG was replaced with GTG to construct strain cgH-8; (9) Based on strain cgH-8, gltA The start codon ATG was replaced with GTG to construct strain cgH-9; (10) Based on strain cgH-9, PPC The original gene promoter was replaced with P tuf Promoter, construct strain cgH-10; (11) Based on strain cgH-10, knock out pck Genes, construct strain cgH-11; (12) Based on strain cgH-11, pyk1 The original gene promoter was replaced with P tuf Promoter, construct strain cgH-12; (13) Based on strain cgH-12, pyk2 The original gene promoter was replaced with P tuf Promoter, construct strain cgH-13; (14) Based on strain cgH-13, overexpress on plasmid pEC-xk99E. thrE Genes were used to construct strain cgH-14.

5. The application of the recombinant genetically engineered bacteria of claim 1 in the fermentation preparation of L-homoserine.

6. The application as described in claim 5, characterized in that, The fermentation was carried out in a shake flask according to the following steps: the recombinant genetically engineered bacteria in the glycerol tube were streaked on an LB agar plate and cultured at 30 °C for 48 h to obtain single colonies; single colonies from the plate were picked and inoculated into LB medium and cultured at 30 °C and 200-220 rpm for 14-16 h to obtain primary seed culture; the primary seed culture was inoculated into seed medium at a volume concentration of 1% and cultured at 30 °C and 200-220 rpm for 12 h to obtain secondary seed culture; The secondary seed culture was inoculated into the fermentation medium at a volume concentration of 5%, and cultured for 48 h until fermentation was complete, yielding a fermentation broth containing L-homoserine. The fermentation broth was then separated and purified to obtain L-homoserine. The seed culture medium consisted of: glucose 25 g / L, urea 1.25 g / L, yeast extract 4 g / L, potassium dihydrogen phosphate 1 g / L, magnesium sulfate heptahydrate 0.5 g / L, threonine 0.5 g / L, methionine 0.5 g / L, with water as the solvent and a pH of 7.

0. The fermentation medium consisted of: glucose 50 g / L, yeast extract 4 g / L, ammonium sulfate 20 g / L, potassium dihydrogen phosphate 1 g / L, magnesium sulfate heptahydrate 0.5 g / L, manganese sulfate monohydrate 0.01 g / L, ferrous sulfate heptahydrate 0.01 g / L, vitamin B1 1 mg / L, vitamin B6 6 mg / L, biotin 0.025 mg / L, and vitamin B1 1 mg / L. 12 0.2 g / L, threonine 0.5 g / L, methionine 0.5 g / L, adjust pH to 7.0 with CaCO3, sterilize at 115℃ for 30 min; if the recombinant genetically engineered bacteria contain plasmid pEC-xk99E, add 25 mg / L kanamycin to the culture medium.

7. The application as described in claim 6, characterized in that, The fermentation is carried out in a fermenter according to the following steps: the recombinant genetically engineered bacteria in the glycerol tube are streaked on an LB agar plate and cultured at 30°C for 48 h to obtain single colonies; single colonies from the plate are picked and inoculated into LB medium and cultured at 30°C and 200-220 rpm for 14-16 h to obtain primary seed culture; the primary seed culture is inoculated into seed medium at a volume concentration of 5% and cultured at 30°C and 200-220 rpm for 12 h to obtain secondary seed culture; The secondary seed culture was inoculated into a fermenter containing fermentation medium at a volume concentration of 10%. Fermentation was carried out at 30℃, 300-900 rpm, and an aeration rate of 2 V / V / min. When the pH was higher than 7.2, automatic feeding was activated. Feeding was stopped when the pH was lower than 7.

2. The culture was incubated for 76 h to obtain a fermentation broth containing L-homoserine. The fermentation medium in the fermenter consisted of: glucose 90 g / L, corn steep liquor 10 g / L, yeast extract 5 g / L, ammonium sulfate 8 g / L, dipotassium hydrogen phosphate 4 g / L, magnesium sulfate heptahydrate 4 g / L, ferrous sulfate heptahydrate 1.5 g / L, manganese sulfate monohydrate 50 mg / L, zinc sulfate heptahydrate 20 mg / L, copper sulfate 20 mg / L, and VB1, VB3, VB5, VB6, and VB6. 12 Each of the following ingredients was added at a concentration of 10 mg / L: biotin 0.5 mg / L, threonine 2 g / L, and methionine 1 g / L. The solvent was water, and the pH was adjusted to 7.2 with 60% ammonia. The feed culture medium consisted of: 600 g / L glucose, 40 g / L ammonium sulfate, 2 g / L threonine, and 1 g / L methionine. The solvent was water, and the pH was adjusted to 7.2 with 60% ammonia.